INSIGHTS ON CLINICAL TRIAL DESIGN
-
![Protocol Design Choices]( "Protocol Design Choices That Trigger IRB And Regulatory Requirements")
Protocol Design Choices That Trigger IRB And Regulatory RequirementsLearn how protocol choices like AI, adaptive designs, and decentralized methods impact IRB review, participant protections, consent, and key regulatory requirements in clinical research.
-
![Breaking The Trial Bottleneck Smarter, Faster Paths To Patients]( "Breaking The Trial Bottleneck: Smarter, Faster Paths To Patients")
Breaking The Trial Bottleneck: Smarter, Faster Paths To PatientsAI is speeding clinical trials — but silos and complexity persist. Discover how connected systems and automation can enable faster, more adaptive development.
-
![GettyImages-2152658176 oncology, doctor, patient]( "Pioneering Strategies For Early-Phase Oncology Trials")
Pioneering Strategies For Early-Phase Oncology TrialsAs the field advances, adaptive methodologies and regulatory shifts redefine early-phase oncology trials, promoting efficiency, flexibility, and equitable access.
-
![GettyImages-1663374966-lab-microscope-mask-research-study]( "Navigating Project Optimus And The Rapidly Changing Oncology Development Landscape")
Navigating Project Optimus And The Rapidly Changing Oncology Development LandscapeProject Optimus and adaptive trial designs are reshaping oncology development, improving patient outcomes, and streamlining approval pathways.
-
FDA Finalizes Psychedelic Drug Guidance: What Sponsors Need To Know8/24/2026
FDA's July 2026 final guidance on psychedelic drug clinical investigations sets expectations for sponsors developing psilocybin, LSD, and MDMA therapies. Learn what it means for your program.
-
Data Privacy And Trust In China's Clinical Trials2/4/2026
China’s evolving privacy laws are reshaping how global trials operate. Sponsors that prioritize transparency and participant confidence can meet compliance demands while building lasting trust.
-
Completed Clinical Trials Continued To Climb In 20246/19/2025
Data collected in this report reflects a shift toward sustained growth, reflecting rapid advancement in therapeutic areas such as oncology, autoimmune/inflammation, and central nervous system studies.
-
Bring Your Own Device (BYOD) Clinical Trials4/8/2025
Bring Your Own Device (BYOD) is revolutionizing clinical trials by enabling participants and researchers to use their own smartphones, tablets, or computers to collect and manage data.
-
When Early CRO Wins Quietly Create Long-Term Study Risk8/13/2026
Discover how overemphasizing early trial milestones can compromise long-term execution. Learn key strategies to build sustainable operational frameworks for lasting study success.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![GettyImages-1414481878 clinical trial, patient, diversity]( "How Trial Compass Is Solving Psychiatric Trial Enrollment")
Psychiatric trials have long been among the most difficult to enroll. From treatment-resistant depression (TRD) and PTSD to cognitive and neuro disorders, sponsors are facing the same challenges over and over again:
- Narrow I/E criteria that don’t translate into real-world patients
- Sites with limited behavioral health infrastructure
- Lack of patient trust and trial awareness in psychiatric populations
- Professional patients
- Rating scales aren’t used in clinical practices
But what if recruitment didn’t have to start with a gamble?
-
![clinical-trials-cros-GettyImages-1346675527]( "Deliver Supply Without Friction. Maintain Control At Every Step")
Learn how clinical supply organizations can reduce manual effort, strengthen compliance, improve global coordination, and maintain control across evolving clinical trial supply chains.
-
![GettyImages-2160908575-patient-care-nurse]( "The Problem-Solving, Patient Advocate Team That Every Trial Needs")
Patient Kindness is a supplemental layer of premium support that offers a more seamless clinical trial experience for patients and caregivers with more complex or nuanced needs.
-
![GettyImages-1420647055 payments]( "Our Technology")
Built From The Ground Up
Block Clinical understood from the beginning that intuitive technology that integrates openly with other systems and suppliers is the key to a streamlined, affordable solution.
-
![iStock-187467661-quality-control-inspection]( "Navigating The Use Of Controlled Substances In Clinical Trials Using IRT")
Sponsor organizations that want to use controlled substances in clinical studies must manage the associated regulatory and logistical requirements. Read how this can be challenging for emerging biopharma.
